BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 27589731)

  • 1. Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.
    Lau KM; To KF
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of GPR30 stimulates GTP-binding of Gαi1 protein to sustain activation of Erk1/2 in inhibition of prostate cancer cell growth and modulates metastatic properties.
    Lau KM; Ma FM; Xia JT; Chan QKY; Ng CF; To KF
    Exp Cell Res; 2017 Jan; 350(1):199-209. PubMed ID: 27908592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.
    Clarke R; Liu MC; Bouker KB; Gu Z; Lee RY; Zhu Y; Skaar TC; Gomez B; O'Brien K; Wang Y; Hilakivi-Clarke LA
    Oncogene; 2003 Oct; 22(47):7316-39. PubMed ID: 14576841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
    Bonkhoff H
    Prostate; 2018 Jan; 78(1):2-10. PubMed ID: 29094395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and Effects of Estrogen Receptors in Prostate Cancer: Associated Molecular Mechanisms.
    Ramírez-de-Arellano A; Pereira-Suárez AL; Rico-Fuentes C; López-Pulido EI; Villegas-Pineda JC; Sierra-Diaz E
    Front Endocrinol (Lausanne); 2021; 12():811578. PubMed ID: 35087479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New insights into the role of estogens and their receptors in prostate cancer].
    Bonkhoff H; Motherby H; Fixemer T
    Urologe A; 2003 Dec; 42(12):1594-601. PubMed ID: 14668987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation.
    Lafront C; Germain L; Weidmann C; Audet-Walsh É
    Sci Rep; 2020 Mar; 10(1):4024. PubMed ID: 32132580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
    Meyer MR; Barton M
    Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen.
    Lindsey SH; Chappell MC
    Gend Med; 2011 Dec; 8(6):343-54. PubMed ID: 22153880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.
    Prossnitz ER; Arterburn JB
    Pharmacol Rev; 2015 Jul; 67(3):505-40. PubMed ID: 26023144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implications of estrogens and their receptors for the development and progression of prostate cancer].
    Bonkhoff H; Fixemer T
    Pathologe; 2005 Nov; 26(6):461-8. PubMed ID: 16220300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
    Bonkhoff H; Berges R
    Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx).
    Kampa M; Notas G; Pelekanou V; Troullinaki M; Andrianaki M; Azariadis K; Kampouri E; Lavrentaki K; Castanas E
    Steroids; 2012 Aug; 77(10):959-67. PubMed ID: 22406407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.